Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i

    Metformin and sodium-glucose-cotransporter-2 inhibitors (SGLT2i) are cornerstone therapies for managing hyperglycemia in diabetes. However, their detailed impacts on metabolic processes, particularly within th...

    Makoto Harada, Jonathan Adam, Marcela Covic, Jianhong Ge in Cardiovascular Diabetology (2024)

  2. Article

    Open Access

    Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center

    mpMRI is routinely used to stratify the risk of clinically significant prostate cancer (csPCa) in men with elevated PSA values before biopsy. This study aimed to calculate a multivariable risk model incorporat...

    Matthias Jahnen, Tanja Hausler, Valentin H. Meissner in World Journal of Urology (2024)

  3. Article

    Open Access

    Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy

    Patients with localized prostate cancer (PC) are faced with a wide spectrum of therapeutic options at initial diagnosis. Following radical prostatectomy (RP), PC patients may experience regret regarding their ...

    Lukas Lunger, Valentin H. Meissner, Benedikt C. G. Kopp, Andreas Dinkel in BMC Urology (2023)

  4. Article

    Open Access

    Association between short-term exposure to air pollution and COVID-19 mortality in all German districts: the importance of confounders

    The focus of many studies is to estimate the effect of risk factors on outcomes, yet results may be dependent on the choice of other risk factors or potential confounders to include in a statistical model. For...

    Gregor Miller, Annette Menzel, Donna P. Ankerst in Environmental Sciences Europe (2022)

  5. Article

    Open Access

    Accommodating heterogeneous missing data patterns for prostate cancer risk prediction

    We compared six commonly used logistic regression methods for accommodating missing risk factor data from multiple heterogeneous cohorts, in which some cohorts do not collect some risk factors at all, and deve...

    Matthias Neumair, Michael W. Kattan in BMC Medical Research Methodology (2022)

  6. Article

    Open Access

    Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance

    The safety of active surveillance (AS) in favorable intermediate-risk (FIR) prostate cancer (PCa) remains uncertain. To provide guidance on clinical decision-making, we examined long-term and pathological outc...

    Valentin H. Meissner, Mira Woll, Donna P. Ankerst in World Journal of Urology (2021)

  7. Article

    Open Access

    Diversity of cancer-related identities in long-term prostate cancer survivors after radical prostatectomy

    Individuals affected by cancer need to integrate this experience into their personal biography as their life continues after primary therapy, leading to substantial changes in self-perception. This study ident...

    Matthias Jahnen, Eike Mynzak, Valentin H. Meissner, Stefan Schiele in BMC Cancer (2021)

  8. Article

    Open Access

    No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance

    To assess whether a first-degree family history or a fatal family history of prostate cancer (PCa) are associated with postoperative upgrading and upstaging among men with low risk and favourable intermediate-...

    Kathleen Herkommer, Nikola Maier, Donna P. Ankerst in World Journal of Urology (2021)

  9. Article

    Open Access

    Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools

    Online clinical risk prediction tools built on data from multiple cohorts are increasingly being utilized for contemporary doctor-patient decision-making and validation. This report outlines a comprehensive da...

    Johanna Tolksdorf, Michael W. Kattan in BMC Medical Research Methodology (2019)

  10. No Access

    Article

    Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy

    We aimed to determine if family history (FH) of prostate cancer (PC) influenced cancer control after radical prostatectomy (RP).

    Mark Thalgott, Martina Kron, Johannes M. Brath in World Journal of Urology (2018)

  11. Article

    Open Access

    A case control study of sarcosine as an early prostate cancer detection biomarker

    Sarcosine has been investigated as a prostate cancer biomarker with mixed results concerning its predictive power. We performed a case–control evaluation of the predictive value of serum sarcosine for early de...

    Donna P. Ankerst, Michael Liss, David Zapata, Josef Hoefler, Ian M. Thompson in BMC Urology (2015)

  12. No Access

    Article

    Daily growth of European beech (Fagus sylvatica L.) on moist sites is affected by short-term drought rather than ozone uptake

    Daily stem growth was reduced by drought with high significance, but not affected by ozone uptake or drought–ozone interaction. Increasing air temperature showed capacity of compensating negati...

    Angelika R. Kühn, Sonja Grill, Manuela Baumgarten, Donna P. Ankerst in Trees (2015)

  13. No Access

    Article

    Association of tree and plot characteristics with microhabitat formation in European beech and Douglas-fir forests

    Process-orientated, unmanaged forest remnants are not sufficient for halting the loss of forest biodiversity. Thus, integrated biodiversity-promoting management for forest inhabitants is needed. Microhabitats,...

    Susanne Winter, Josef Höfler, Alexa K. Michel in European Journal of Forest Research (2015)

  14. No Access

    Article

    Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group

    To assess the applicability of the Prostate Cancer Prevention Trial High Grade (Gleason grade ≥ 7) Risk Calculator (PCPTHG) in ten international cohorts, representing a range of populations.

    Donna P. Ankerst, Andreas Boeck, Stephen J. Freedland in World Journal of Urology (2014)

  15. No Access

    Article

    Prostate cancer incidence and survival in immigrants to Sweden

    The large international variation in the incidence of prostate cancer (PC) is well known but the underlying reasons are not understood. We want to compare PC incidence and survival among immigrants to Sweden i...

    Kari Hemminki, Donna P. Ankerst, Jan Sundquist in World Journal of Urology (2013)

  16. No Access

    Article

    Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group

    To evaluate the discrimination, calibration, and net benefit performance of the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) across five European randomized study of screening for prostate cancer ...

    Donna P. Ankerst, Andreas Boeck, Stephen J. Freedland in World Journal of Urology (2012)

  17. Article

    Editorial for special issue on epidemiology and prevention of prostate cancer

    Ian M. Thompson, Donna P. Ankerst in World Journal of Urology (2012)

  18. Article

    Open Access

    Association analysis of frost tolerance in rye using candidate genes and phenotypic data from controlled, semi-controlled, and field phenoty** platforms

    Frost is an important abiotic stress that limits cereal production in the temperate zone. As the most frost tolerant small grain cereal, rye (Secale cereale L.) is an ideal cereal model for investigating the gene...

    Yongle Li, Andreas Böck, Grit Haseneyer, Viktor Korzun, Peer Wilde in BMC Plant Biology (2011)

  19. No Access

    Chapter

    Pitfalls in Prostate Cancer Biomarker Evaluation Studies

    Biomarker studies in prostate cancer research aim to discover new markers or novel uses of prostate-specific antigen (PSA) to complement or replace PSA as the existing standard for screening. These studies oft...

    Donna P. Ankerst in Prostate Cancer Screening (2009)

  20. No Access

    Chapter

    Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator

    The Prostate Cancer Prevention Trial (PCPT) Prostate Cancer Risk Calculator provides a single probability of prostate cancer and of high-grade disease (Gleason grade

    Donna P. Ankerst, Ian M. Thompson in Prostate Cancer Screening (2009)

previous disabled Page of 2